8-K
SILICON LABORATORIES INC. (SLAB)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OFTHE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 2, 2022
SILICON LABORATORIES INC.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 000-29823 | 74-2793174 |
|---|---|---|
| (State or Other Jurisdiction | (Commission File Number) | (IRS Employer |
| of Incorporation) | Identification No.) | |
| 400 West Cesar Chavez, Austin, TX | 78701 | |
| --- | --- | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code:
(512) 416-8500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Common Stock, $0.0001 par value | SLAB | The NASDAQ Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act of 1934. ¨
Item 2.02. Results of Operations and Financial Condition
On February 2 2022, Silicon Laboratories Inc. (“Silicon Laboratories”) issued a press release describing its results of operations for its fiscal quarter ended January 1, 2022. A copy of the press release is attached as Exhibit 99 to this report.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
| 99 | Press Release of Silicon Laboratories<br> Inc. dated February 2, 2022 |
|---|---|
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
Use of Non-GAAP Financial Information
From time to time, Silicon Laboratories provides certain non-GAAP financial measures as additional information relating to its operating results. The non-GAAP financial measurements provided in the press release furnished herewith do not replace the presentation of Silicon Laboratories’ GAAP financial results. These additional measurements merely provide supplemental information to assist investors in analyzing Silicon Laboratories’ financial position and results of operations; however, these measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies.
Non-GAAP financial measures used by Silicon Laboratories include non-GAAP gross margin, non-GAAP research and development expense, non-GAAP selling, general and administrative expense, non-GAAP operating income, non-GAAP interest expense, non-GAAP tax expense, non-GAAP net income and non-GAAP diluted earnings per share. Silicon Laboratories has chosen to provide this information to investors because it believes that such supplemental information enables them to perform meaningful comparisons of past, present and future operating results, and as a means to highlight the results of core ongoing operations.
Non-GAAP financial measures are adjusted by the following items:
| · | Stock compensation expense – represents charges for employee stock awards issued under Silicon Laboratories’ stock-based compensation plans. Stock compensation expense is excluded from non-GAAP financial measures because it is a non-cash expense, and excluding such expense provides meaningful supplemental information regarding core ongoing operations. |
|---|---|
| · | Intangible asset amortization – primarily represents charges for the amortization of intangibles assets, such as core and developed technology, customer relationships and trademarks, acquired in connection with business combinations. Intangible asset amortization is excluded from non-GAAP financial measures because it is a non-cash expense, and excluding such expense provides meaningful supplemental information regarding core ongoing operations. |
| --- | --- |
| · | Acquisition and disposition related items – primarily including the following: charges for the fair value write-up associated with inventory acquired; adjustments to the fair value of acquisition-related contingent consideration; and acquisition-related costs of a business combination or disposition-related costs of a business divestiture, such as costs for attorneys, investment bankers, accountants and other third party service providers. Acquisition and disposition related items are excluded from non-GAAP financial measures because excluding such amounts provides meaningful supplemental information regarding core ongoing operations. |
| --- | --- |
| · | Termination costs, impairments and fair value adjustments – primarily include costs associated with certain employee terminations, asset impairments and fair value adjustments resulting from observable price changes. Termination costs, impairments and fair value adjustments are excluded from non-GAAP financial measures because excluding such amounts provides meaningful supplemental information regarding core ongoing operations. |
| --- | --- |
| · | Fair value adjustments to investments – primarily include gains and/or losses associated with certain fair value adjustments for equity investments accounted for by the equity method of accounting or cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes. Fair value adjustments are excluded from non-GAAP financial measures because these generally are non-cash, non-operating activity during the period of adjustment, relate to activity in entities outside those of Silicon Labs, and excluding such expense/gain provides meaningful supplemental information regarding core operations. |
| --- | --- |
| · | Interest expense adjustments – represents charges for the amortization of the debt discount on Silicon Laboratories’ convertible senior notes, losses on the extinguishment of convertible debt and losses on the termination of interest rate swap agreements. Such amounts are excluded from non-GAAP financial measures because they are non-cash expenses and/or excluding such amounts provides meaningful supplemental information regarding core ongoing operations. |
| --- | --- |
| · | Income tax adjustments – primarily include the following: the current and deferred income tax effects of the above non-GAAP adjustments; other indirect impacts of excluding stock-based compensation; and the income tax impact of certain intercompany license arrangements for technology acquired in business combinations. Income tax adjustments are excluded from non-GAAP financial measures because excluding such amounts provides meaningful supplemental information regarding core ongoing operations. |
| --- | --- |
Pursuant to the requirements of Regulation G, we have provided in the press release furnished with this report a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures.
The information in this report, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. The information contained therein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Silicon Laboratories, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
EXHIBIT INDEX
| Exhibit No. | Description |
|---|---|
| 99 | Press Release of Silicon<br> Laboratories Inc. dated February 2, 2022 |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SILICON LABORATORIES INC. | |
|---|---|
| February 2, 2022 | /s/ John C. Hollister |
| Date | John C. HollisterSenior Vice President andChief Financial Officer(Principal Financial Officer) |
Exhibit 99
Silicon LabsAnnounces Record IoT Revenue for Fourth Quarter 2021
IoTLeader Enters 2022 With Strong Momentum Across Wireless Portfolio
AUSTIN, Texas – February 2, 2022– Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, reported strong financial results for the fourth quarter, which ended January 1, 2022. Revenue exceeded the top of the guidance range at $209 million, up 13% sequentially and 43% year-on-year. Fourth quarter and annual results herein are from “continuing operations” unless explicitly stated.
“I’m proud of the team’s disciplined execution as we transitioned to focus solely on the Internet of Things. We delivered record IoT revenue and gained momentum across our entire wireless portfolio,” said Matt Johnson, President, and Chief Executive Officer. “We’re well-positioned to take advantage of the accelerating IoT growth across smart home, medical, industrial, and commercial segments in 2022.”
Fourth Quarter Financial Highlights
| · | Revenue increased to $209 million, up 13% sequentially and 43% year-on-year |
|---|
Results on a GAAP basis:
| · | GAAP gross margin was 61.3% |
|---|---|
| · | GAAP R&D expenses were $72 million |
| --- | --- |
| · | GAAP SG&A expenses were $53 million |
| --- | --- |
| · | GAAP operating income as a percentage of revenue was 1.3% |
| --- | --- |
| · | GAAP diluted earnings per share were $0.13 |
| --- | --- |
Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, restructuring charges, non-cash interest expense and other costs associated with convertible notes, and certain other items as set forth in the reconciliation tables were as follows:
| · | Non-GAAP gross margin was 61.4% |
|---|---|
| · | Non-GAAP R&D expenses were $57 million |
| --- | --- |
| · | Non-GAAP SG&A expenses were $37 million |
| --- | --- |
| · | Non-GAAP operating income as a percentage of revenue was 16.3% |
| --- | --- |
| · | Non-GAAP diluted earnings per share were $0.77 |
| --- | --- |
Business Highlights
| · | In<br> January, Silicon Labs announced the BG24 and MG24 2.4 GHz wireless SoCs<br> and a new software toolkit that bring AI/ML acceleration and wireless high performance<br> to battery-powered edge devices. Matter-ready, the ultra-low-power BG24 and MG24 families<br> support multiple wireless protocols and incorporate PSA Level 3 Secure Vault™<br> protection, important for diverse smart home, medical and industrial applications. |
|---|
| · | In Q4, Silicon Labs launched our new Z-Wave 800 SoCs and modules for the Z-Wave smart home and automation ecosystem. This expansion<br>on the company’s award-winning Series 2 platform provides developers with sub-GHz connectivity for Z-Wave Mesh and Z-Wave Long Range,<br>which is ideal for the smart home as well as multi-dwelling units, hospitality, and lighting applications while supporting both devices<br>and gateways. |
|---|---|
| · | Silicon Labs is proud to be named the Global Semiconductor Alliance’s Most Respected Public Semiconductor Company among our<br>peers, a testament to our strong performance and values. We were also ranked one of the best companies to work for in our industry based<br>on the annual Great Place to Work survey of our employees. |
| --- | --- |
| · | On January 27, 2022, Silicon Labs’ board of directors approved a new share repurchase program that authorizes the company to<br>buy back up to $250 million of the company’s common stock through the end of the fiscal year. |
| --- | --- |
| · | Silicon Labs announced that Sherri Luther, Chief Financial Officer of Lattice Semiconductor (NASDAQ: LSCC), joined Silicon Labs’<br>board of directors effective January 2, 2022. Sherri is a well-respected industry leader, bringing 30 years of experience in mergers<br>and acquisitions, global supply chain optimization, and deep financial expertise. Additionally, Sumit Sadana was appointed Lead Director<br>for Silicon Labs. Sumit succeeds Bill Wood, who remains a member of the board. Sumit currently serves as Executive Vice President, Chief<br>Business Officer, and interim Chief Financial Officer at Micron Technology (NASDAQ: MU). |
| --- | --- |
Business Outlook
The company expects first quarter revenue to be in the range of $220 to $230 million. The company also estimates the following results:
On a GAAP basis:
| · | GAAP gross margin of approximately 63% |
|---|---|
| · | GAAP operating expenses of approximately $128 million |
| --- | --- |
| · | GAAP effective tax rate of approximately 37% |
| --- | --- |
| · | GAAP diluted earnings per share to be between $0.15 to $0.25 |
| --- | --- |
On a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the reconciliation tables:
| · | Non-GAAP gross margin of approximately 63% |
|---|---|
| · | Non-GAAP operating expenses of approximately $105 million |
| --- | --- |
| · | Non-GAAP effective tax rate of approximately 30% |
| --- | --- |
| · | Non-GAAP diluted earnings per share between $0.58 to $0.68 |
| --- | --- |
Earnings Webcast and Conference Call
Silicon Labs will host an earnings conference call to discuss the quarterly results and answer questions at 7:30 am CDT today. An audio webcast will be available on Silicon Labs’ website (www.silabs.com) under Investor Relations. In addition, the company will post an audio recording of the event at silabs.com/investors and make a replay available through March 2, 2022, online or by calling (877) 344-7529 (US) or (412) 317-0088 (international) and entering access code 4909009.
About Silicon Labs
Silicon Labs (NASDAQ: SLAB) is a leader in secure, intelligent wireless technology for a more connected world. Our integrated hardware and software platform, intuitive development tools, thriving ecosystem, and robust support make us an ideal long-term partner in building advanced industrial, commercial, home and life applications. We make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with innovative solutions that transform industries, grow economies, and improve lives. silabs.com
Forward-Looking Statements
This press release contains forward-looking statements based on Silicon Labs’ current expectations. The words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “plan,” “project,” “will,” and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: the effect of the Skyworks transaction on the ability of Silicon Labs to retain and hire key personnel and maintain relationships with its customers, suppliers, advertisers, partners and others with whom it does business, or on its operating results and businesses generally; risks associated with the disruption of management’s attention from ongoing business operations due to such transaction; the timing and scope of anticipated share repurchases, and/or dividends; the impact of COVID-19 on the U.S. and global economy, including the restrictions on travel and transportation and other actions taken by governmental authorities and disruptions to the business of our customers or our global supply chain that have occurred or may occur in the future, the ongoing impact of COVID-19 on our employees and our ability to provide services to our customers and respond to their needs; risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs’ distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; debt-related risks; capital-raising risks; the competitive and cyclical nature of the semiconductor industry; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs’ products and its networks and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. The level of share repurchases and/or dividends depends on market conditions and the level of other uses of cash. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.
Note to editors: Silicon Laboratories, Silicon Labs, the “S”symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks oftheir respective holders.
CONTACT: Austin Dean, Investor Relations Manager, +1 (512) 532-9432, Austin.Dean@silabs.com
Silicon Laboratories Inc.
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
| Three Months Ended | Year Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| January 1, <br><br>2022 | January 2, <br><br>2021 | January 1, <br><br>2022 | January 2, <br><br>2021 | |||||||||
| Revenues | $ | 208,680 | $ | 145,829 | $ | 720,860 | $ | 510,928 | ||||
| Cost of revenues | 80,849 | 61,894 | 295,468 | 216,083 | ||||||||
| Gross profit | 127,831 | 83,935 | 425,392 | 294,845 | ||||||||
| Operating expenses: | ||||||||||||
| Research and development | 71,705 | 60,554 | 273,208 | 235,185 | ||||||||
| Selling, general and administrative | 53,487 | 41,792 | 185,022 | 166,748 | ||||||||
| Operating expenses | 125,192 | 102,346 | 458,230 | 401,933 | ||||||||
| Operating income (loss) | 2,639 | (18,411 | ) | (32,838 | ) | (107,088 | ) | |||||
| Other income (expense): | ||||||||||||
| Interest income and other, net | 2,595 | 1,206 | 5,696 | 9,027 | ||||||||
| Interest expense | (6,628 | ) | (8,219 | ) | (31,033 | ) | (34,142 | ) | ||||
| Loss from continuing operations before income taxes | (1,394 | ) | (25,424 | ) | (58,175 | ) | (132,203 | ) | ||||
| Provision (benefit) for income taxes | 884 | (2,702 | ) | 13,427 | (14,602 | ) | ||||||
| Equity-method earnings | 7,791 | 1,375 | 13,728 | 2,116 | ||||||||
| Income (loss) from continuing operations | 5,513 | (21,347 | ) | (57,874 | ) | (115,485 | ) | |||||
| Income (loss) from discontinued operations, net of income taxes | (8,611 | ) | 30,295 | 2,175,273 | 128,016 | |||||||
| Net income (loss) | $ | (3,098 | ) | $ | 8,948 | $ | 2,117,399 | $ | 12,531 | |||
| Basic earnings (loss) per share: | ||||||||||||
| Continuing operations | $ | 0.14 | $ | (0.49 | ) | $ | (1.35 | ) | $ | (2.64 | ) | |
| Net income | $ | (0.08 | ) | $ | 0.20 | $ | 49.44 | $ | 0.29 | |||
| Diluted earnings (loss) per share: | ||||||||||||
| Continuing operations | $ | 0.13 | $ | (0.49 | ) | $ | (1.35 | ) | $ | (2.64 | ) | |
| Net income | $ | (0.08 | ) | $ | 0.20 | $ | 47.78 | $ | 0.28 | |||
| Weighted-average common shares outstanding: | ||||||||||||
| Basic | 38,965 | 43,895 | 42,830 | 43,775 | ||||||||
| Diluted | 41,031 | 44,729 | 44,315 | 44,372 |
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
| January 2, <br><br>2021 | ||||
|---|---|---|---|---|
| Assets | ||||
| Current assets: | ||||
| Cash and cash equivalents | 1,074,623 | $ | 202,720 | |
| Short-term investments | 964,582 | 521,963 | ||
| Accounts receivable, net | 98,313 | 95,169 | ||
| Inventories | 49,307 | 47,861 | ||
| Prepaid expenses and other current assets | 51,748 | 87,103 | ||
| Current assets of discontinued operations | -- | 21,005 | ||
| Total current assets | 2,238,573 | 975,821 | ||
| Property and equipment, net | 146,516 | 135,803 | ||
| Goodwill | 376,389 | 376,389 | ||
| Other intangible assets, net | 118,978 | 163,483 | ||
| Other assets, net | 77,839 | 76,675 | ||
| Non-current assets of discontinued operations | -- | 265,316 | ||
| Total assets | 2,958,295 | $ | 1,993,487 | |
| Liabilities and Stockholders’ Equity | ||||
| Current liabilities: | ||||
| Accounts payable | 47,327 | $ | 54,949 | |
| Current portion of convertible debt, net | 450,599 | 134,480 | ||
| Deferred revenue and returns liability | 13,849 | 12,986 | ||
| Other current liabilities | 157,052 | 81,650 | ||
| Current liabilities of discontinued operations | -- | 433 | ||
| Total current liabilities | 668,827 | 284,498 | ||
| Convertible debt, net | -- | 428,945 | ||
| Other non-current liabilities | 77,044 | 79,752 | ||
| Non-current liabilities of discontinued operations | -- | 451 | ||
| Total liabilities | 745,871 | 793,646 | ||
| Commitments and contingencies | ||||
| Stockholders’ equity: | ||||
| Preferred stock – 0.0001 par value; 10,000 shares authorized; no shares issued | -- | -- | ||
| Common stock – 0.0001 par value; 250,000 shares authorized; 38,481 and 43,925 shares issued and outstanding at January 1, 2022 and January 2, 2021, respectively | 4 | 4 | ||
| Additional paid-in capital | -- | 204,359 | ||
| Retained earnings | 2,214,839 | 993,664 | ||
| Accumulated other comprehensive income (loss) | (2,419 | ) | 1,814 | |
| Total stockholders’ equity | 2,212,424 | 1,199,841 | ||
| Total liabilities and stockholders’ equity | 2,958,295 | $ | 1,993,487 |
All values are in US Dollars.
Silicon Laboratories Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
| Year Ended | ||||||
|---|---|---|---|---|---|---|
| January 1, <br><br>2022 | January 2, <br><br>2021 | |||||
| Operating Activities | ||||||
| Net income | $ | 2,117,399 | $ | 12,531 | ||
| Adjustments to reconcile net income to cash provided by (used in) operating activities of continuing operations: | ||||||
| Income from discontinued operations, net of income taxes | (2,175,273 | ) | (128,016 | ) | ||
| Depreciation of property and equipment | 18,051 | 16,267 | ||||
| Amortization of other intangible assets | 44,505 | 42,569 | ||||
| Amortization of debt discount and debt issuance costs | 22,767 | 21,433 | ||||
| Loss on extinguishment of convertible debt | 3,370 | 4,060 | ||||
| Stock-based compensation expense | 56,842 | 49,454 | ||||
| Equity-method earnings | (13,728 | ) | (2,116 | ) | ||
| Deferred income taxes | (3,414 | ) | (6,533 | ) | ||
| Changes in operating assets and liabilities: | ||||||
| Accounts receivable | (3,144 | ) | (17,612 | ) | ||
| Inventories | (1,510 | ) | 9,148 | |||
| Prepaid expenses and other assets | 44,664 | (50,664 | ) | |||
| Accounts payable | (7,704 | ) | 15,263 | |||
| Other current liabilities and income taxes | 2,109 | 3,215 | ||||
| Deferred revenue and returns liability | 863 | (6,694 | ) | |||
| Other non-current liabilities | (14,599 | ) | 28,856 | |||
| Net cash provided by (used in) operating activities of continuing operations | 91,198 | (8,839 | ) | |||
| Investing Activities | ||||||
| Purchases of marketable securities | (1,541,971 | ) | (519,567 | ) | ||
| Sales and maturities of marketable securities | 1,095,041 | 497,357 | ||||
| Purchases of property and equipment | (28,577 | ) | (18,088 | ) | ||
| Purchases of other assets | (1,158 | ) | (1,210 | ) | ||
| Acquisitions of businesses, net of cash acquired | -- | (316,809 | ) | |||
| Net cash used in investing activities of continuing operations | (476,665 | ) | (358,317 | ) | ||
| Financing Activities | ||||||
| Proceeds from issuance of debt | -- | 845,000 | ||||
| Payments on debt | (140,572 | ) | (624,737 | ) | ||
| Repurchases of common stock | (1,150,044 | ) | (16,287 | ) | ||
| Payment of taxes withheld for vested stock awards | (22,239 | ) | (18,124 | ) | ||
| Proceeds from the issuance of common stock | 14,183 | 15,015 | ||||
| Net cash provided by (used in) financing activities of continuing operations | (1,298,672 | ) | 200,867 | |||
| Discontinued Operations | ||||||
| Operating activities | (191,642 | ) | 144,557 | |||
| Investing activities | 2,747,684 | (2,694 | ) | |||
| Net cash provided by discontinued operations | 2,556,042 | 141,863 | ||||
| Increase (decrease) in cash and cash equivalents | 871,903 | (24,426 | ) | |||
| Cash and cash equivalents at beginning of period | 202,720 | 227,146 | ||||
| Cash and cash equivalents at end of period | $ | 1,074,623 | $ | 202,720 |
Non-GAAP Financial Measurements
In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.
The non-GAAP financial measurements do not replace the presentation of Silicon Labs’ GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs’ financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.
Unaudited Reconciliation of GAAP to Non-GAAPFinancial Measures
(In thousands, except per share data)
| Three Months Ended January 1, 2022 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-GAAP Income Statement Items | GAAP Measure | GAAP Percent of Revenue | **** | Stock Compensation Expense | Intangible Asset Amortization | Termination Costs | Non- GAAP Measure | Non-GAAP Percent of Revenue | **** | |||||||||
| Revenues | $ | 208,680 | ||||||||||||||||
| Gross profit | 127,831 | 61.3 | % | $ | 267 | $ | -- | $ | -- | $ | 128,098 | 61.4 | % | |||||
| Research and development | 71,705 | 34.4 | % | 6,796 | 7,753 | -- | 57,156 | 27.4 | % | |||||||||
| Selling, general and administrative | 53,487 | 25.6 | % | 12,863 | 2,781 | 939 | 36,904 | 17.7 | % | |||||||||
| Operating income | 2,639 | 1.3 | % | 19,926 | 10,534 | 939 | 34,038 | 16.3 | % | |||||||||
| Three<br> Months Ended January 1, 2022 | ||||||||||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Non-GAAP Earnings Per Share – Continuing Operations | GAAP Measure | Stock Compensation Expense* | Intangible Asset Amortization* | Termination Costs* | Investment Fair Value Adjustments* | Interest Expense Adjustments* | Income Tax Adjustments | Non- GAAP Measure | ||||||||||
| Income from continuing<br> operations | $ | 5,513 | $ | 19,926 | $ | 10,534 | $ | 939 | $ | (7,856 | ) | $ | 5,106 | $ | (2,670 | ) | $ | 31,492 |
| Diluted shares outstanding | 41,031 | 41,031 | ||||||||||||||||
| Diluted earnings per share | $ | 0.13 | $ | 0.77 |
* Represents pre-tax amounts.
Unaudited Forward-Looking Statements RegardingBusiness Outlook
(In millions, except per share data)
| Three Months Ending April 2, 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Business Outlook | GAAP Measure | Non-GAAP Adjustments** | Non-GAAP Measure | ||||||
| Gross margin | 63 | % | 0 | % | 63 | % | |||
| Operating expenses | $ | 128 | $ | (23 | ) | $ | 105 | ||
| Effective tax rate | 37 | % | (7 | )% | 30 | % | |||
| Diluted earnings per share - low | $ | 0.15 | $ | 0.43 | $ | 0.58 | |||
| Diluted earnings per share - high | $ | 0.25 | $ | 0.43 | $ | 0.68 |
** Non-GAAP adjustments include the following estimates: stock compensation expense of $13 million, intangible asset amortization of $10 million, and the associated tax impact from the aforementioned items**.**